SHAPING MARKETS

+ Read More

CO-CREATING HEALTH

+ Read More

ABOUT US

01

We are a boutique healthcare firm
that operates at the intersection of
Science, Policy And Business.

02

We partner with Life Science
Innovators And Medical
Foundations to shape markets and
co-create the future of healthcare.

03

We help deliver the benefits of
innovation to Patients and a
sustainable return to Developers.

04

We work directly with Institutional
Leaders spanning regulatory
agencies, payers, health technology
assessors, and patient and medical
societies. We Understand And Speak
The Language of the various actors in a healthcare system.

GALEN/ATLANTICA SHAPES MARKETS

SO PATIENTS BENEFIT FROM NEW TREATMENTS AND TECHNOLOGIES

We have worked across the medicines lifecycle with 8 of the top 10 global
pharmaceutical companies

Examples of Our Work

  • Novel regulatory pathways for sustainable trials

    The best thinking of developers, KOLs and patients to evolve the regulatory pathway in a chronic disease

  • Development strategy for first wave of combinations

    Maximize the benefit to patients and commercial value of a lead asset

  • Pathogen-specific approval pathway

    We convened “The key event in changing the regulatory approach to antibiotics. This was a real sea-change and everything else has followed form it.”
    -John Rex, Former Senior VP and Head of Infection at describing a pilot of Expanded Scientific Advice convened by Galen/Atlantica’s founders.

Examples of Our Work

  • Differentiated value for a new drug in a crowded space

    Integrated medical, patient and societal benefits into compelling value story

  • Secure access to the first treatment for a serious condition

    One of the most successful drug launches of the past decade

  • New reward models to sustain antibiotics innovation

    Novel approaches to incentivize pressing public health needs

Examples of Our Work

  • New treatment paradigm to change disease course

    Partner with medical experts and patients to drive the transition

  • Policy strategies to enable patient benefit from innovation

    Address disease awareness and prioritization, health system capacity, funding and care pathway

  • Oncology
  • Neuroscience
  • Immunology

GALEN/ATLANTICA CO-CREATES HEALTH

WE MOBILIZE SENIOR HEALTHCARE LEADERS TO
USHER IN THE FUTURE OF HEALTHCARE

De-risking drug development:

Expanded Scientific Advice

We created a new forum for drug developers to secure simultaneous feedback from regulators, payers, and patients

Read More

Aligning a sector on a critical mission:

Industry Declaration on AMR

We co-developed the industry plan for overcoming antimicrobial resistance signed by 100 companies and released at the World Economic Forum

Read More

Managing the complexity of clinical decision-making:

CDS Quality Summit

We convened healthcare leaders to articulate clear expectations for robust, high-quality clinical decision support seen as essential for effective medicine

Read More

PIAdT

Preparing for patient access to breakthrough treatments:

Pathways for the Introduction of Alzheimer’s disease Treatments

We convened drug developers and reimbursement authorities to address the value and funding challenges raised by AD treatments

Read More

Mobilizing a multi-national response:

Wellcome Trust Science Summit

We led a 30 nation summit integrating human and environmental health to prioritize interventions and inform the United Nations

Read More

Raising treatment aspirations:

Primary Progressive Multiple
Sclerosis policy forum

We raised the aspirations of the MS community for the diagnosis and care of the most severe form of the disease

Read More

GALEN/ATLANTICA CO-CREATES HEALTH

WE CREATE COALITIONS TO PURSUE OBJECTIVES THAT
REQUIRE MULTIPLE PARTIES TO WORK TOGETHER

Convening
  • Complex healthcare problems call for multi-party solutions
  • We build trusted relationships with the most senior leaders in healthcare
  • Patient interest is the common denominator
Content
  • We make sense of ambiguous and highly technical problems
  • We co-create concrete solutions with institutional leaders, experts and patients
  • We do the heavy lifting on content creation
Courage
  • We earn the right to lead through integrity and insight
  • We encourage principled pursuit of diverging interests
  • We create communities of shared purpose
“Galen/Atlantica brings intellectual rigor to
complex, ambiguous and technical problems”
Tim Jinks, Head of the Drug Resistant Infections program
at the Wellcome Trust

FIRM LEADERSHIP

MATT DIVER AND NICHOLAS GERTLER FOUNDED
GALEN/ATLANTICA IN BOSTON IN 2015

Matt Diver

Founder

Nicholas Gertler

Founder

GALEN/ATLANTICA IN PRINT

Who will these new professionals be? What will they look like? Well, they will look more like Matt and Nicholas than a ‘graduate’ of P&G. Yes, they will have all the tools of segmentation and pricing and strong analytical capabilities. They will need to start with the same basic checklist that McKinsey published. But they will also have some experience with social and regulatory policy as both Matt and Nicholas do. They will need to have worked in places like Washington and Brussels and have a feel for the sausage-making process of policy. Most importantly, they will have empathy – the ability to put themselves into the shoes of others.

– Bill Matassoni,

former head of marketing at BCG and McKinsey,
founder of The McKinsey Quarterly, and author of Marketing Saves the World (2020)

CONTACT US

We are based in Boston,
Massachusetts,
the biotech capital
of the world.

We look forward to hearing from you.